Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Green Dot Stock Is Up Because Investors Think an Activist Can Fix the Pre-Paid Card Company
Green Dot shares are surging after news that an activist shareholder took a stake in the payments company prompted analysts to take a more upbeat view. (GDOT) stock (ticker: GDOT) was up 6.7% in Tuesday trading to about $33.75 a share after activist investor Starboard Value said in securities filings it had built up just over a 9% position in the provider of pre-paid debit cards. Green Dot stock is down 55% over the last 12 months, compared to a 21% rise in the S&P 500.
https://finance.yahoo.com/m/016ec226-4eef-398e-b9e5-16a56b50b021/green-dot-stock-is-up-because.html
Interesting, PaySign is redesigning their web site and have changed their logo. check it out! paysign.com
It would be nice if PAYS would post earnings early and blow these shorts clean off the planet.
LOL, I suspected as much...
Someone's mighty positive on the Mar 17.5 PAYS calls, 500 at .05
Over 50K downloads - WOW, pun intended....
Somebody ought to file a complaint with the SEC on Aurelius Value for spreading false information. This would make for a good episode on American Greed.
chilar - Right now TD Ameritrade is 40%
Hey I'm not negative on PAYS - I'm just commenting on what I see happening.
LOL some of the selling the last 2 days is because of margin calls...
Zacks Analyst Blog Highlights: Global Payments, Mastercard, Fiserv and PaySign
Chicago, IL – November 18, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Global Payments Inc. GPN, Mastercard Inc. MA, Fiserv, Inc. FISV and PaySign Inc. PAYS.
https://finance.yahoo.com/news/zacks-analyst-blog-highlights-global-142002822.html
Still lots of shorts in this, end of Oct report now shows 31.92%. Down from the 38% from a month ago. Some have covered but there still is a huge group that haven't. Won't take much to start the stampede. What a beautiful thought...
Great write up from Simply Wall St - their bottom line:
Earnings vs Savings Rate: PAYS's forecast earnings growth (39.4% per year) is above the savings rate (2.7%).
Earnings vs Market: PAYS's earnings (39.4% per year) are forecast to grow faster than the US market (14.1% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PAYS's revenue (35.1% per year) is forecast to grow faster than the US market (7.2% per year).
High Growth Revenue: PAYS's revenue (35.1% per year) is forecast to grow faster than 20% per year.
Picking up a few PROF today Mr D, we will see, like the company and it's "products"....
Excuse my exuberance, some of the smarter shorts are starting to push through the exit, no panic yet in MHO.... just sayin....
shorts are jamming the exit, their hair is on fire, too funny.....
Analyst firm - RT ResearchTeam has PAYS now at Accumulate, up from Hold as of today Nov 6th.
Speck, History doesn't always repeat but it sure does rhyme a lot. Wish I had been the author of that.... just sayin......
Don't fall into the shorts game plan. They're in control of those who can be panic'ed.
How about PaySign re-loadable cards as the answer to "What's in your wallet"
Short interest came down 1st 2 weeks of the month, about 5 percent....
Was 10.08 million, as of 9/30/19 - came down to 9.50 million shares as of 10/15/19.
What we need is an event that will cause them to leave RAPIDLY.
Perhaps earnings in a couple of weeks!
Source - NASDAQ site.
With a 38 percent short INTEREST in this stock as of 9/15/2019 we might be starting to see the makings of a SQUEEZE.
Best part: The delayed plasma programs are now planned to be live by the end of September and are expected to materially increase the company’s monthly plasma industry revenue.
No issues other than trying to keep the fake news in check.
There are no lawsuits, just standard group of ambulance chasers soliciting idiots.
He's in his mid 50's I believe, time to enjoy the fruits of his labors IMHO
I read that his sale was part of a 10b5-1 plan that allows insiders to sell on a schedule unrelated to news, got this from the yehoo board.
The company’s financial results are scheduled to be released shortly before the market opens that day (instead of The company’s financial results are scheduled to be released shortly after the market closes that day).
Too bad blu did that D. I used to support the website thru paying for it to stop the adds, but I stopped several years ago. I'll post there with PAYS info when I can then though I very seldom even look at it.
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement that we filed with the United States Securities and Exchange Commission, which we refer to as the “SEC”, utilizing a shelf registration or continuous offering process. Under this shelf registration or continuous offering process, after the SEC declares our registration statement effective, we may sell any combination of the securities described in this prospectus in one or more offerings up to a total amount of $150,000,000.
This prospectus provides a general description of the securities that we may offer. Each time we sell securities, we will provide you with a prospectus supplement containing specific information about the terms of the securities being offered. A prospectus supplement may include a discussion of any risk factors in addition to those included or incorporated herein under the heading “Risk Factors” or other special considerations applicable to those securities or to us. A prospectus supplement may also add, update or change information in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you must rely on the information in the prospectus supplement. You should read both this prospectus and any prospectus supplement together with additional information described under the heading “Where You Can Find More Information”.
The registration statement containing this prospectus, including exhibits to the registration statement, provides additional information about us and the securities offered under this prospectus. The registration statement can be read at the SEC’s website or at the SEC’s public reference room mentioned under the heading “Where You Can Find More Information”.
We may sell securities to underwriters who will sell the securities to the public on terms fixed at the time of sale. In addition, the securities may be sold by us directly to purchasers or through dealers or agents designated from time to time. If we, directly or through agents, solicit offers to purchase the securities, we reserve the sole right to accept and, together with any agents, to reject, in whole or in part, any of those offers.
Any prospectus supplement will contain the names of the underwriters, dealers or agents, if any, together with the terms of offering, the compensation of those underwriters and the net proceeds to us. Any underwriters, dealers or agents participating in the offering may be deemed “underwriters” within the meaning of the United States Securities Act of 1933, as amended, which we refer to as the “Securities Act”.
All references in this prospectus to “Paysign”, “the Company”, “we”, “us”, “our Company”, “the Registrant” or “our” refer to Paysign, Inc., a Nevada corporation, and its subsidiaries, and their respective predecessor entities for the applicable periods, considered as a single enterprise.
Unless otherwise stated, currency amounts in this prospectus and any prospectus supplement are stated in United States Dollars (“$”).
Here's summary of it:
PROSPECTUS SUMMARY
This summary highlights selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus. This summary is not complete and does not contain all of the information that you need to consider in making your investment decision. You should carefully read the entire prospectus, including the risks of investing in our securities discussed under the section entitled “Risk Factors” contained in this prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus. You should also carefully read the information incorporated by reference into this prospectus, including our financial statements and related notes and the exhibits to the registration statement of which this prospectus forms a part.
The Company
We are a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications. Our payment solutions are utilized by our corporate customers as a means to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. Public sector organizations can utilize our payment solutions to disburse public benefits or for internal payments. We market our prepaid card solutions under our Paysign brand. As we are a payment processor and prepaid card program manager, we derive our revenue from all stages of the prepaid card lifecycle. We provide a card processing platform consisting of proprietary systems and innovative software applications based on the unique needs of our clients. We have extended our processing business capabilities through our proprietary Paysign platform. Through the Paysign platform, we provide a variety of services including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service.
The Paysign platform was built on modern cross-platform architecture and designed to be highly flexible, scalable and customizable. The platform has allowed us to significantly expand our operational capabilities by facilitating our entry into new markets within the payments space through its flexibility and ease of customization. The Paysign platform delivers cost benefits and revenue building opportunities to our partners.
We have developed prepaid card programs for corporate incentive and rewards including, but not limited to, consumer rebates and rewards, donor compensation, healthcare reimbursement payments and pharmaceutical payment assistance. We are expanding our product offerings to include additional corporate incentive products, payroll cards, demand deposit accounts accessible with a debit card, travel cards, and expense reimbursement cards. Our cards are sponsored by our issuing bank partners.
We manage all aspects of the debit card lifecycle, from managing the card design and approval processes with partners and networks, to production, packaging, distribution, and personalization. We also oversee inventory and security controls, renewals, lost and stolen card management and replacement. We deploy a fully staffed, in-house customer service department which utilizes bi-lingual customer service representatives, Interactive Voice Response, and two-way short message service messaging.
To date, we have issued millions of prepaid debit cards under programs implemented for Fortune 500 companies, multinationals, as well as top pharmaceutical manufacturers, universities and social media companies.
Depending on the program selected by the client, we generate the following types of revenues: setup charges; customized software development fees; data processing and report generation fees; transaction fees from each transaction by a cardholder; interchange fees; card fulfillment fees; fees related to customer service and administrative fees.
3
Corporate Information
Our principal executive offices are located at 1700 W. Horizon Ridge Parkway, Suite 200, Henderson, Nevada 89012, and our telephone number is (702) 453-2221. Our website address is www.paysign.com. Our website and the information contained on, or that can be accessed through, our website will not be deemed to be incorporated by reference in, and are not considered part of, this prospectus. You should not rely on our website or any such information in making your decision whether to purchase our securities.
USE OF PROCEEDS
Unless we otherwise specify in any applicable prospectus supplement, we expect to use the net proceeds from our sale of securities for general corporate purposes, which may include repayment of future indebtedness, funding future acquisitions, strategic investments, stock repurchases, capital expenditures and working capital. Pending such use, we may temporarily invest net proceeds in short-term, interest bearing, investment-grade securities. Because of the number and variability of factors that will determine our use of such proceeds, the Company’s ultimate use might vary substantially from its planned use. You may not agree with how we allocate or spend the proceeds from an offering of our securities. We may pursue acquisitions, collaborations or other opportunities that do not result in an increase in the market value of our securities, including the market value of our common stock, and that may increase our losses. We will disclose any proposal to use the net proceeds from any offering of securities in connection with an acquisition in the prospectus supplement relating to such offering.
DESCRIPTIONS OF SECURITIES WE MAY OFFER
This prospectus contains summary descriptions of the common stock, preferred stock, warrants and units that we may offer and sell from time to time. The preferred stock may be exchangeable for and/or convertible into shares of common stock or another series of preferred stock. When one or more of these securities are offered in the future, a prospectus supplement will explain the particular terms of the securities and the extent to which these general provisions may apply. These summary descriptions and any summary descriptions in the applicable prospectus supplement do not purport to be complete descriptions of the terms and conditions of each security and are qualified in their entirety by reference to our Articles of Incorporation, as amended, our Bylaws, as amended, and applicable Nevada law and any other documents referenced in such summary descriptions and from which such summary descriptions are derived. If any particular terms of a security described in the applicable prospectus supplement differ from any of the terms described herein, then the terms described herein will be deemed superseded by the terms set forth in that prospectus supplement.
We may issue securities in book-entry form through one or more depositaries named in the applicable prospectus supplement. Each sale of a security in book-entry form will settle in immediately available funds through the applicable depositary, unless otherwise stated. We will issue the securities only in registered form, without coupons, although we may issue the securities in bearer form if so specified in the applicable prospectus supplement. If any securities are to be listed or quoted on a securities exchange or quotation system, the applicable prospectus supplement will say so.
4
DESCRIPTION OF CAPITAL STOCK
General
The following is a summary of our capital stock and certain provisions of our Amended and Restated Articles of Incorporation, as amended, and Amended and Restated Bylaws, as amended, copies of which are on file with the SEC as exhibits to previous SEC filings. See “Where You Can Find More Information” elsewhere in this prospectus for information on where you can obtain copies of our Amended and Restated Articles of Incorporation and Amended and Restated Bylaws, which have been filed with and are publicly available from the SEC. This summary does not purport to be complete and is qualified in its entirety by the provisions of our Amended and Restated Articles of Incorporation, our Amended and Restated Bylaws and applicable provisions of the Nevada Revised Statutes.
Common Stock
We are currently authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. As of July 19, 2019, there were 47,556,912 shares of common stock outstanding. Holders of our common stock have no preemptive rights and no right to convert their common stock into any other securities. All outstanding shares of our common stock are fully paid and non-assessable. Holders of our common stock:
· have equal ratable rights to dividends from funds legally available therefore, if declared by our Board of Directors,
· are entitled to share ratably in all our assets available for distribution to holders of common stock upon our liquidation, dissolution or winding up;
· do not have preemptive, subscription or conversion rights or redemption or sinking fund provisions;
· are entitled to one non-cumulative vote per share on all matters on which stockholders may vote at all meetings of our stockholders and for directors.
Preferred Stock
We are currently authorized to issue 25,000,000 shares of preferred stock, par value $0.001 per share. As of July 19, 2019, there were no shares of preferred stock outstanding. Our Board, without further stockholder approval, may issue preferred stock in one or more series from time to time and fix or alter the designations, relative rights, priorities, preferences, qualifications, limitations and restrictions of the shares of each series. The rights, preferences, limitations and restrictions of different series of preferred stock may differ with respect to dividend rates, amounts payable on liquidation, voting rights, conversion rights, redemption provisions, sinking fund provisions and other matters. Our Board may authorize the issuance of preferred stock, which ranks senior to our common stock for the payment of dividends and the distribution of assets on liquidation. In addition, our Board can fix limitations and restrictions, if any, upon the payment of dividends on our common stock to be effective while any shares of preferred stock are outstanding.
Paysign Initiated at Buy by Canaccord Genuity
Today 7:01 AM ET (Dow Jones)Print
Paysign Initiated at Buy by Canaccord Genuity
Ratings actions from Benzinga: https://www.benzinga.com/stock/PAYS/ratings
(END) Dow Jones Newswires
July 02, 2019 07:01 ET (11:01 GMT)
Paysign Price Target Announced at $17.00/Share by Canaccord Genuity
Ratings actions from Benzinga: https://www.benzinga.com/stock/PAYS/ratings
(END) Dow Jones Newswires
July 02, 2019 07:01 ET (11:01 GMT)
DJ Paysign Price Target Announced at $17.00/Share by Canaccord Genuity
Ratings actions from Benzinga: https://www.benzinga.com/stock/PAYS/ratings
(END) Dow Jones Newswires
July 02, 2019 07:01 ET (11:01 GMT)
Thanks Chilar and D, lots of GOOD news here for sure!
I would almost suspect news of some sort given the steady uptick of the share price all day friday, also it's the first day of the second half. perhaps the "deal" will be unveiled. JMHO of course.
More new blood brought on board....
https://finance.yahoo.com/news/paysign-inc-names-matt-lanford-123100478.html
Interesting part of news release...."Matt is a proven industry leader whose expertise will be invaluable as we expand our products digitally and add mobile wallet capabilities,” said Mark Newcomer"
If I read this correctly sounds like PaySign will be going into the world of smart phone app, great news IMHO!
Sunrise must obviously be in the running to offer the re-loadable card that PaySign is wanting to introduce soon with a statement like
" Sunrise Banks is the most innovative bank empowering the under-served to achieve. We seek to radically change the way urban communities and under-served people thrive by empowering them to achieve their aspirations"
I would think they either are the "banker" of this card or are in the running if there is some sort of decision process still going on here.
Seems big things and mergers are happening with the big boys in payments/cards etc world.
https://realmoney.thestreet.com/jim-cramer/jim-cramer-global-payments-tsys-apple-card-goldman-it-s-all-about-paypal-14972077?puc=yahoo&cm_ven=YAHOO&yptr=yahoo
I'm a waiting on June 3rd. I'd be surprised if there wasn't some sort of announcement on this new card and partner. I'm sure they would like some new excitement for the June 11th meeting.